Don’t perform screening mammography in asymptomatic patients with normal exams who have less than five-year life expectancy.
|Rationale and Comments:||Mammography identifies breast cancers at early stages and has demonstrated benefits in reducing mortality and morbidity from a breast cancer diagnosis. There is minimal benefit of screening mammography in women with life expectancies of < five years. Additionally, there is a risk of false positives and potential procedures that do not provide patients improved outcomes.|
|References:||• Schonberg MA, Breslau ES, McCarthy EP. Targeting of mammography screening according to life expectancy in women aged 75 and older. J Am Geriatr Soc. 2013;61:388-395.
• Walter LC, Schonberg MA. Screening mammography in older women: a review. JAMA. 2014;311:1336-1347.